- Home
- EWBC vs ASND Comparison
EWBC vs ASND Comparison
Compare EWBC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWBC
- ASND
- Stock Information
- Founded
- EWBC 1998
- ASND 2006
- Country
- EWBC United States
- ASND Denmark
- Employees
- EWBC N/A
- ASND N/A
- Industry
- EWBC Major Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- EWBC Finance
- ASND Health Care
- Exchange
- EWBC Nasdaq
- ASND Nasdaq
- Market Cap
- EWBC 14.6B
- ASND 12.2B
- IPO Year
- EWBC 1999
- ASND 2015
- Fundamental
- Price
- EWBC $102.97
- ASND $217.66
- Analyst Decision
- EWBC Buy
- ASND Strong Buy
- Analyst Count
- EWBC 12
- ASND 17
- Target Price
- EWBC $124.00
- ASND $245.76
- AVG Volume (30 Days)
- EWBC 806.6K
- ASND 460.8K
- Earning Date
- EWBC 10-21-2025
- ASND 11-12-2025
- Dividend Yield
- EWBC 2.31%
- ASND N/A
- EPS Growth
- EWBC 14.57
- ASND N/A
- EPS
- EWBC 9.07
- ASND N/A
- Revenue
- EWBC $2,572,339,000.00
- ASND $758,592,045.00
- Revenue This Year
- EWBC $8.23
- ASND $104.98
- Revenue Next Year
- EWBC $7.40
- ASND $79.91
- P/E Ratio
- EWBC $11.44
- ASND N/A
- Revenue Growth
- EWBC 6.63
- ASND 97.46
- 52 Week Low
- EWBC $68.27
- ASND $118.03
- 52 Week High
- EWBC $113.95
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- EWBC 49.48
- ASND 63.81
- Support Level
- EWBC $98.08
- ASND $188.07
- Resistance Level
- EWBC $107.04
- ASND $202.41
- Average True Range (ATR)
- EWBC 2.57
- ASND 8.66
- MACD
- EWBC 0.45
- ASND 0.84
- Stochastic Oscillator
- EWBC 51.03
- ASND 91.87
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.